MAY/JUNE 2010
Big Pharma, Bad Medicine
Photo: Chris Asadian
Marcia Angell
As the boundaries between academic medicine and the pharmaceutical companies dissolve, research, education, and clinical practice suffer.
Adriane Fugh-Berman
Selling Diseases
David Korn
The Challenge of Public Expectations
Howard Brody
The Case of H1N1
Dan W. Brock
No Such Thing As a Free Sample
Frank Britt and Marissa Seligman
A letter challenging Angell’s claims.
Thomas P. Stossel
Unhealthy Opposition: The value of academic-industry relationships
Emma D’Arcy
A Partnership Worth Promoting
Suzanne Gordon
Don’t Forget Nurses
David Bollier
Restore Medicine to the Commons
Marcia Angell responds
A Question of Commitments
Photo: flickr.com/emagic
